Loading...
Back to narrative

Update shared on17 Sep 2025

Fair value Increased 1.91%
AnalystConsensusTarget's Fair Value
CN¥55.34
6.3% overvalued intrinsic discount
17 Sep
CN¥58.80
Loading
1Y
79.3%
7D
-7.4%

With both the future P/E ratio and discount rate remaining essentially unchanged, the consensus analyst price target for New China Life Insurance saw only a slight upward revision from CN¥54.30 to CN¥55.34.


What's in the News


  • Board approved interim cash dividend of RMB 0.67 per share, totaling approximately RMB 2,090 million for the first half of 2025, pending shareholder approval.
  • Board meeting held to review interim financial results for the first six months of 2025, discuss interim dividend payment, and address other business matters.

Valuation Changes


Summary of Valuation Changes for New China Life Insurance

  • The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from CN¥54.30 to CN¥55.34.
  • The Future P/E for New China Life Insurance remained effectively unchanged, moving only marginally from 10.82x to 11.04x.
  • The Discount Rate for New China Life Insurance remained effectively unchanged, moving only marginally from 7.80% to 7.92%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.